RightFit Trial Directory

Leukemia clinical trials in Jacksonville, FL

16 recruiting leukemia studies with a site in Jacksonville, FL.

All trials in Jacksonville, FL · All Leukemia trials

RecruitingPhase 2NCT06317662

Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia

Sponsor: National Cancer Institute (NCI)

Gainesville, FL · Hollywood, FL · Jacksonville, FL · +112 more sites

RecruitingPhase 1 / Phase 2NCT07109219

Study of AZD4512 Monotherapy or in Combination With Anticancer Agents in Participants With Acute Lymphoblastic Leukemia

Sponsor: AstraZeneca

Jacksonville, FL · +5 more sites

RecruitingPhase 1NCT07424833

A Study of APG-3288 in Relapsed/Refractory Blood Cancers

Sponsor: Ascentage Pharma Group Inc.

Jacksonville, FL · +4 more sites

RecruitingPhase 2NCT03516617

Acalabrutinib With or Without Obinutuzumab in Treating Patients With Early-Stage Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Sponsor: Mayo Clinic

Jacksonville, FL · +2 more sites

RecruitingPhase 3NCT07277231

A Study to Investigate Sonrotoclax (BGB-11417) Plus Zanubrutinib (BGB-3111) Compared With Venetoclax Plus Acalabrutinib in Adults With Previously Untreated Chronic Lymphocytic Leukemia

Sponsor: BeOne Medicines

Jacksonville, FL · Miami, FL · Tampa, FL · +19 more sites

RecruitingPhase 3NCT04293562

A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations

Sponsor: Children's Oncology Group

Fort Lauderdale, FL · Fort Myers, FL · Gainesville, FL · +183 more sites

RecruitingPhase 2 / Phase 3NCT03013998

Study of Biomarker-Based Treatment of Acute Myeloid Leukemia

Sponsor: Beat AML, LLC

Gainesville, FL · Jacksonville, FL · Orlando, FL · +28 more sites

RecruitingPhase 1 / Phase 2NCT04726241

The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study

Sponsor: PedAL BCU, LLC

Fort Lauderdale, FL · Fort Myers, FL · Gainesville, FL · +161 more sites

RecruitingPhase not listedNCT05702645

A Study to Learn More About the Health of Persons With Down Syndrome After Treatment for Acute Leukemia

Sponsor: Children's Oncology Group

Fort Myers, FL · Hollywood, FL · Jacksonville, FL · +69 more sites

RecruitingPhase 3NCT06104566

Global Trial in APG2575 for Patients With CLL/SLL

Sponsor: Ascentage Pharma Group Inc.

Jacksonville, FL · Miami Beach, FL · +9 more sites

RecruitingPhase not listedNCT01790152

Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment

Sponsor: Children's Oncology Group

Fort Myers, FL · Gainesville, FL · Hollywood, FL · +66 more sites

RecruitingPhase 3NCT06428019

A Study to Evaluate the Risk of Tumor Lysis Syndrome (TLS) in Adult Participants Receiving Oral Venetoclax in Combination With Intravenously Infused Obinutuzumab or Oral Acalabrutinib for Previously Untreated Chronic Lymphocytic Leukemia (CLL)

Sponsor: AbbVie

Gainesville, FL · Jacksonville, FL · Orange City, FL · +29 more sites

RecruitingPhase not listedNCT06279572

Immune Profile of Acute Myeloid Leukemia Patients Receiving Azacitidine Plus Venetoclax Induction Chemotherapy

Sponsor: Mayo Clinic

Jacksonville, FL · +2 more sites

RecruitingPhase 4NCT06876649

A Master Protocol to Evaluate the Long-Term Safety of (LY3527727) Pirtobrutinib

Sponsor: Eli Lilly and Company

Jacksonville, FL · Miami, FL · Sarasota, FL · +17 more sites

RecruitingPhase 1NCT06191887

B-Cell Activating Factor Receptor (BAFFR)-Based Chimeric Antigen Receptor T-Cells With Fludarabine and Cyclophosphamide Lymphodepletion for the Treatment of Relapsed or Refractory B-cell Hematologic Malignancies

Sponsor: Mayo Clinic

Jacksonville, FL

RecruitingPhase 1NCT04167696

Study in Relapsed/Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome Patients to Determine the Recommended Dose of CYAD-02

Sponsor: Celyad Oncology SA

Jacksonville, FL · +1 more sites

Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.